InChI=1S/C39H49N3O8S/c1- 24- 13- 12- 17- 28- 35(46) 29(22- 30- 36(28) 51- 23- 33(44) 41- 30) 40- 32(43) 21- 27(49- 3) 16- 10- 5- 4- 6- 11- 18- 31(25(2) 34(24) 45) 50- 38(48) 39(19- 20- 39) 42- 37(47) 26- 14- 8- 7- 9- 15- 26/h4- 6,10- 11,13- 14,16,22,25,27,31,34,45- 46H,7- 9,12,15,17- 21,23H2,1- 3H3,(H,40,43) (H,41,44) (H,42,47) /b5- 4+,11- 6+,16- 10+,24- 13-![](images/invisible_space.gif) |
YIMYDHUFVYSTEY-WUWQZELJSA-N |
COC1CC(=O)Nc2cc3NC(=O)CSc3c(CC\C=C(C)/C(O)C(C)C(C\C=C\C=C\C=C\1)OC(=O)C1(CC1)NC(=O)C1=CCCCC1)c2O |
|
Streptomyces sp.
(NCBI:txid1931)
|
of strain
TC 1190
See:
PubMed
|
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(11E,13E,15E,21Z)- 20,26- dihydroxy- 10- methoxy- 19,21- dimethyl- 3,8- dioxo- 3,4,7,8,9,10,17,18,19,20,23,24- dodecahydro- 2H- 25,6- (metheno)[1,4]thiazino[3,2- d]azacyclotricosin- 18- yl 1- [(cyclohex- 1- en- 1- ylcarbonyl)amino]cyclopropanecarboxylate
|
(6E,8E,10E,16Z)- 15,28- Dihydroxy- 5- methoxy- 14,16- dimethyl- 3,24- dioxo- 22- thia- 2,25- diazatricyclo[18.7.1.021,26]octacosa- 1(28),6,8,10,16,20,26- heptaen- 13- yl 1- [(1- cyclohexen- 1- ylcarbonyl)amino]cyclopropanecarboxylate
|
IUPAC
|
8670452
|
Reaxys Registry Number
|
Reaxys
|
10994816
|
PubMed citation
|
Europe PMC
|
|